Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia

European Journal of Biochemistry

Volumn 243, Issue 1-2, 1997, Pages 100-109

  Stelter, Felix ^a   Bernheiden, Martin ^a   Menzel, René ^a   Jack, Robert S ^a   Witt, Sabine ^a   Fan, Xiaolong ^a   Pfister, Martin ^a   Schütt, Christine ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

CD14; Lipopolysaccharide; Mutagenesis

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CHO CELL; DELETION MUTANT; ESCHERICHIA COLI; MUTATION; PRIORITY JOURNAL;

EID: 0031019324     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1997.00100.x     Document Type: Article

References (29)

1. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. & Mathison, J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science 249, 1431-1433.
2. Kitchens, R. L. & Munford, R. S. (1995) Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway, J. Biol. Chem. 270, 9904-9910.
3. Gegner, J. A., Ulevitch, R. J. & Mathison, J. C. (1995) Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14, J. Biol. Chem. 270, 5320-5325.
4. Weinstein, S. L., June, C. H. & DeFranco, A. L. (1993) Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14, J. Immunol. 151, 3829-3838.
5. Delude, R. L., Fenton, M. J., Savedra, R. Jr, Perera, P. Y., Vogel, S. N., Thieringer, R. & Golenbock, D. T. (1994) CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity, J. Biol. Chem. 269, 22253-22260.
6. Dentener, M. A., Bazil, V., von Asmuth, E. J., Ceska, M. & Buurman, W. A. (1993) Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages, J. Immunol. 150, 2885-2891.
7. Schütt, C., Schilling, T., Grunwald, U., Schönfeld, W. & Krüger, C. (1992) Endotoxin neutralizing capacity of soluble CD14, Res. Immunol. 143, 71-78.
8. Lee, J. D., Kravchenko, V., Kirkland, T. N., Han, J., Mackman, N., Moriarty, A., Leturcq, D., Tobias, P. S. & Ulevitch, R. J. (1993) Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin, Proc. Natl Acad. Sci. USA 90, 9930-9934.
9. Jack, R. S., Grunwald, U., Stelter, F., Workalemahu, G. & Schütt, C. (1995) Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria, Eur. J. Immunol. 25, 1436-1441.
10. Grunwald, U., Fan, X., Jack, R. S., Workalemahu, G., Kallies, A., Stelter, F. & Schütt, C. (1996) Monocytes can phagocytose gramnegative bacteria by a mechanism dependent on CD14, J. Immunol. 157, 4119-4125.
11. Bazil, V. & Strominger, J. L. (1991) Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes, J. Immunol. 147, 1567-1574.
12. Durieux, J. J., Vita, N., Popescu, O., Guette, F., Calzada-Wack, J., Munker, R., Schmidt, R. E., Lupker, J., Ferrara, P., Ziegler-Heitbrock, H. W. L. & Labeta, M. O. (1994) The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes, Eur. J. Immunol. 9, 2006-2012.
13. Bufler, P., Stiegler, G., Schuchmann, M., Hess, S., Krüger, C., Stelter, F., Schütt, C., Eckershorn, C. & Engelmann, H. (1995) Soluble LPS receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants, Eur. J. Immunol. 25, 604-610.
14. Stelter, F., Pfister, M., Bernheiden, M., Jack, R. S., Bufler, P., Engelmann, H. & Schütt, C. (1996) The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different sCD14 isoforms, Eur. J. Biochem. 236, 457-464.
15. Grunwald, U., Krüger, C. & Schult, C. (1993) Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function, Circ. Shock 39, 220-225.
16. Haziot, A., Rong, G. W., Bazil, V., Silver, J. & Goyert, S. M. (1994) Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood, J. Immunol 152, 5868-5876.
17. Haziot, A., Rong, G. W., Lin, X. L., Silver, J. & Goyert, S. M. (1995) Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide), J. Immunol. 154, 6529-6532.
18. Frey, E. A., Miller, D. S., Gullstein Jahr, T., Sundan, A., Bazil, V., Espevik, T., Finlay, B. B. & Wright, S. D. (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide, J. Exp. Med. 176, 1665-1671.
19. Pugin, J., Schürer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J. & Tobias, P. S. (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14, Proc. Natl Acad. Sci. USA 90, 2744-2748.
20. Haziot, A., Rong, G. W., Silver, J. & Goyert, S. M. (1993) Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide, J. Immunol. 151, 1500-1507.
21. Read, M. A., Cordle, S. R., Veach, R. A., Carlisle, C. D. & Hawiger, J. (1993) Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells, Proc Natl Acad. Sci. USA 90, 9887-9891.
22. Loppnow, H., Stelter, F., Schönbeck, U., Schlüter, C., Ernst, M., Schütt, C. & Flad, H. D. (1995) Endotoxin activates human smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14, Infect. Immun. 63, 1020-1026.
23. Viriyakosol, S. & Kirkland, T. N. (1995) A region of human CD14 required for lipopolysaccharide binding, J. Biol. Chem. 270, 361-368.
24. Juan, T. S. C., Kelley, M. J., Johnson, D. A., Busse, L. A., Hailman, E., Wright, S. D. & Lichenstein, H. S. (1995) Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS, J. Biol. Chem. 270, 1382-1387.
25. McGinley, M. D., Narhi, L. O., Kelley, M. J., Davy, E., Robinson, J., Rohde, M. F., Wright, S. D. & Lichenstein, H. S. (1995) CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide, J. Biol. Chem. 270, 5213-5218.
26. Juan, T. S. C., Hailman, E., Kelley, M. J., Busse, L. A., Davy, E., Empig, C. J., Narhi, L. O., Wright, S. D. & Lichenstein, H. S. (1995) Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64, J. Biol. Chem. 270, 5219-5224.
27. Kirkland, T. N., Finley, F., Leturcq, D., Moriarty, A., Lee, J. D., Ulevitch, R. J. & Tobias, P. S. (1993) Analysis of lipopolysaccharide binding by CD14, J. Biol. Chem. 268, 24818-24823.
28. Kitchens, R. L., Ulevitch, R. J. & Munford, R. S. (1992) Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway, J. Exp. Med. 176, 485-494.
29. Schutt, C., Witt, S., Grunwald, U., Stelter, F., Schilling, T., Fan, X., Marquart, B. P., Bassarab, S. & Krüger, C. (1995) Epitope mapping of CD14 glycoprotein, in Leukocyte typing V (Schlossmann, S. F., Boumsell, L., Gilks, W., Harlan, J. M., Kishimoto, T., Morimoto, C., Ritz, J., Shaw, S., Silverstein, R., Springer, T., Tedder, T. F. & Todd, R. F., eds) pp. 785-788, Oxford University Press, Oxford.